Home・Aktien・Smith & Nephew PLC ADR

Smith & Nephew PLC ADR

Geschlossen

29.21 -1.42

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

29.23

Max

29.73

Schlüsselkennzahlen
By Trading Economics
Einkommen	-29M 303M
Verkäufe	-106M 3.1B
KGV Branchendurchschnitt	20.329 57.371
Dividendenrendite	2.66
Gewinnspanne	9.784
Angestellte	17,000
EBITDA	114M 748M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+8.99% upside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	2.66% 2.23%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-1.1B 12B
Vorheriger Eröffnungskurs	30.63
Vorheriger Schlusskurs	29.21

Smith & Nephew PLC ADR Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Aug. 2026, 22:42 UTC

U.S. Personal Spending Data Set for Release Amid Cautious Optimism and Inflation Concerns, Forecasting 0.2% Growth

24. Aug. 2026, 22:42 UTC

Durable Goods Orders Ex Transportation for July 2026 Expected to Rise by 0.5% Amid Tariff Concerns in Trucking Sector

24. Aug. 2026, 22:42 UTC

Core PCE Price Index Release on August 26 Expected to Show Modest Inflation Increase Amid Fed Rate Policy Scrutiny.

24. Aug. 2026, 22:42 UTC

U.S. PCE Price Index Release Expected to Show Steady Inflation, Influencing Fed's Monetary Policy Outlook Amid Market Caution

24. Aug. 2026, 22:42 UTC

U.S. GDP Growth Rate Expected at 1.5% for Q2 Amid Cautious Investor Sentiment and Geopolitical Tensions

24. Aug. 2026, 22:42 UTC

US Durable Goods Orders Expected to Rise 0.7% in July Amid Mixed Economic Signals

24. Aug. 2026, 22:42 UTC

Analysts Anticipate Resilient Corporate Profits in Q2 2026 Amid Economic Fluctuations and Key Market Indicators.

24. Aug. 2026, 22:42 UTC

U.S. Personal Income Expected to Rise 0.3% in July Amid Cautious Market Sentiment and Inflation Concerns

24. Aug. 2026, 22:42 UTC

Market Anticipates Modest 0.1% Increase in July PCE Price Index Amid Ongoing Inflation Concerns and Stable Fed Interest Rate Outlook

24. Aug. 2026, 22:31 UTC

Mexico's Trade Surplus Expected to Remain Strong Amid U.S.-Canada Tariff Tensions, Data Release on August 27.

24. Aug. 2026, 22:31 UTC

ECB Monetary Policy Meeting Accounts Release on August 27, 2026, to Provide Insights Amid Caution Over Inflation and Geopolitical Tensions.

24. Aug. 2026, 22:31 UTC

Brazil's Unemployment Rate Set for Release on August 27, Expected to Reflect Continued Labor Market Recovery Amid Global Economic Discussions.

24. Aug. 2026, 22:26 UTC

RingCentral Inc. is trading higher in after-market hours, reflecting unusual price action amid geopolitical tensions and investor caution regarding energy prices and economic stability.

24. Aug. 2026, 22:22 UTC

Editas Medicine Inc shares are higher in after-market trading, showing some volatility. No specific news was identified to explain the price movement.

24. Aug. 2026, 22:21 UTC

Neurocrine Biosciences Inc shares are higher in after-market hours, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

24. Aug. 2026, 22:21 UTC

CNO Financial Group Inc shares are higher in after-market trading, reflecting a modest gain since Monday's close, despite no specific news identified.

24. Aug. 2026, 22:21 UTC

India's GDP Growth Rate YoY Release on August 31, 2026 Expected to Reflect Strong Economic Performance Amid Global Pressures.

24. Aug. 2026, 22:16 UTC

News

A federal court upheld an $83.4 million award against Guardant Health for patent infringement, though shares are trading higher in after-market hours.

24. Aug. 2026, 22:16 UTC

ICU Medical Inc shares are higher in after-market hours, maintaining a position above the 20-day moving average and near the one-month range's upper end.

24. Aug. 2026, 22:16 UTC

Public Storage shares are higher in after-market trading, reflecting routine activity with typical fluctuations within a narrow range since Monday's close.

24. Aug. 2026, 22:16 UTC

News

Kenneth S. Courtis bought $3.2 million in Alpha Metallurgical Resources shares, contributing to modest after-market gains following recent insider purchases.

24. Aug. 2026, 22:16 UTC

Allegiant Travel Co shares are higher in after-market trading, despite fluctuations during the session and no specific news to explain the movement.

24. Aug. 2026, 22:16 UTC

Research Frontiers Inc. shares are higher in after-market trading, reflecting a notable increase from Monday's close and strong performance relative to recent averages.

24. Aug. 2026, 22:16 UTC

Starwood Property Trust Inc. shares are roughly flat in after-market trading, amid broader market conditions following three consecutive lower sessions.

24. Aug. 2026, 22:16 UTC

IDEXX Laboratories Inc shares are higher in after-market trading, maintaining gains without significant fluctuations. No specific news was identified to explain the movement.

24. Aug. 2026, 22:16 UTC

Eastgroup Properties Inc. shares are higher in after-market trading, though they remain near the lower end of their one-month trading range.

24. Aug. 2026, 22:16 UTC

US Physical Therapy Inc shares are lower in after-market trading, remaining near the lower end of their one-month range amid broader market caution.

24. Aug. 2026, 22:11 UTC

Capri Holdings Ltd shares rose in after-market trading, continuing a gradual increase despite earlier pulling back from a session high. No specific news was identified.

24. Aug. 2026, 22:11 UTC

Japan's July 2026 unemployment rate forecast at 2.5% raises cautious market sentiment amid potential Bank of Japan interest rate hikes and mixed sector performance.

24. Aug. 2026, 22:11 UTC

Correlated Moves

Citizens Financial Group shares lower in after-market trading, reflecting broader market declines amid rising oil prices and inflation concerns.

Peer-Vergleich

Kursveränderung

Smith & Nephew PLC ADR Prognose

Kursziel

By TipRanks

8.99% Vorteil

12-Monats-Prognose

Durchschnitt 31.89 USD 8.99%

Hoch 33.77 USD

Tief 30 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Smith & Nephew PLC ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Smith & Nephew PLC ADR – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.